Icon

Atrovent HFA - (0.21 mg/Inh ; Inhalation Aerosol)

Ipratropium Bromide Boehringer Ingelheim
0.21 mg/Inh ; Inhalation Aerosol
Less Than $1000 mn
None None
More Than 5
None
None None
ATROVENT HFA is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema
Yes
Atrovent HFA Patent 1
******* *******
  1. *** **, **** : * **** ** ** ***** *** ***** ** *** ***.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.